Back to Search
Start Over
Trial of novel imaging agent for kidney cancer completes enrollment
- Source :
- Urology Times. August, 2022, Vol. 50 Issue 8, p6, 1 p.
- Publication Year :
- 2022
-
Abstract
- Patient enrollment has been completed in the phase 3 ZIRCON study (NCT03849118) exploring TLX250-CDx (DFO-girentuximab-Zr-89), a novel positron emission tomography imaging radiopharmaceutical for clear cell renal cell carcinoma (RCC) being [...]
Details
- Language :
- English
- ISSN :
- 00939722
- Volume :
- 50
- Issue :
- 8
- Database :
- Gale General OneFile
- Journal :
- Urology Times
- Publication Type :
- Periodical
- Accession number :
- edsgcl.717940116